Skip to main content

Published locations for FDA extends review period for anticipated Alzheimer’s drug

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA extends review period for anticipated Alzheimer’s drug

User login

  • Reset your password
  • /content/fda-extends-review-period-anticipated-alzheimers-drug
  • /neurologyreviews/article/235518/alzheimers-cognition/fda-extends-review-period-anticipated
  • /jcomjournal/article/235518/alzheimers-cognition/fda-extends-review-period-anticipated-alzheimers
  • /psychiatry/article/235518/alzheimers-cognition/fda-extends-review-period-anticipated-alzheimers-drug
  • /neurology/article/235518/alzheimers-cognition/fda-extends-review-period-anticipated-alzheimers-drug
  • /clinicalpsychiatrynews/article/235518/alzheimers-cognition/fda-extends-review-period-anticipated